Canton Strategic Holdings (CNTN)

• Market cap: $230M
• 1 day: -6.53%
• 5 days: 1.54%
• 1 month: -0.6%
• 3 months: -34.46%
• 6 months: 28.52%
• Year to date: -2.66%
• 1 year: 130.07%
• 5 years: -99.75%
• 10 years: -99.75%
• Sector: Healthcare
• Industry: Biotechnology

About: Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Employees: 12